An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.

@article{Bedognetti2010AnOR,
  title={An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.},
  author={Davide Bedognetti and Alessandra Rubagotti and Giario Natale Conti and Francesco De Francesca and Ottavio De Cobelli and Luca Canclini and Michele Gallucci and Francesco Aragona and Pasquale Di Tonno and Pietro Cortellini and Giuseppe Martorana and Alberto Lapini and Francesco Boccardo},
  journal={European urology},
  year={2010},
  volume={57 2},
  pages={
          238-45
        }
}
BACKGROUND Bicalutamide monotherapy is a valuable option for prostate cancer (PCa) patients who wish to avoid the consequences of androgen deprivation; however, this treatment induces gynaecomastia and mastalgia in most patients. Tamoxifen is safe and effective in preventing breast events induced by bicalutamide monotherapy without affecting antitumor activity, but possible interference between bicalutamide and tamoxifen remains a matter of concern. To reduce the exposure to tamoxifen, we… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 17 CITATIONS

Gynecomastia in Patients with Prostate Cancer: A Systematic Review

VIEW 9 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

Managing Male Mammary Maladies.

  • European journal of breast health
  • 2018
VIEW 2 EXCERPTS
CITES BACKGROUND

Management of adolescent gynecomastia: an update

  • Acta bio-medica : Atenei Parmensis
  • 2017
VIEW 1 EXCERPT
CITES BACKGROUND

The pharmacotherapy of male hypogonadism besides androgens.

  • Expert opinion on pharmacotherapy
  • 2015
VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 25 REFERENCES

Evaluation of tamoxifen and anastrozole in the prevention of gynecomastia and breast pain induced by bicalutamide monotherapy of prostate cancer.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2005
VIEW 6 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…